Agilent Technologies Inc. and Agendia, Inc. today jointly announced an agreement to expand their relationship to include the development of an RNASeq kit version of Agendia’s currently marketed MammaPrint and BluePrint tests. Agendia’s MammaPrint test provides High-Risk or Low-Risk test re ... more
Agilent Technologies Secures Patent for CGH Assays
Agilent Technologies Inc. announced that it was awarded a significant patent for comparative genomic hybridization methods. CGH methods help researchers study genetics and cancer in both basic and clinical research.
The U.S. patent (No. 8,232,055) has claims for measuring copy number changes in genomic DNA, covering both one-color and two-color assays using oligonucleotide probes and samples with high-sequence complexity, such as human genomic DNA samples.
Agilent’s copy number method, commercially introduced in 2005, uses long oligonucleotide probes, enabling high specificity and sensitivity. For example, samples containing as low as 8 percent abnormal cells may be confidently analyzed with Agilent’s copy number method.
The method was originally developed to improve upon older copy number assays that use long genomic fragments such as bacterial artificial chromosomes. (BACs often contain repetitive regions.) The method also improves upon other oligonucleotide array assays, which depend on sample preparation methods that remove significant portions of the genomic DNA content. Agilent’s higher-resolution platform allows users to detect much smaller genomic aberrations throughout complex genomes.
- Agilent Technologies
- comparative genomic…
- oligonucleotide probes
Agilent Technologies announced that it received three awards at the Annual Conference of China Scientific Instruments (ACCSI) 2017 in Nanjing, China. Agilent received the following awards: Green Product of the Year, Most Popular Scientific Instrument, and Most Influential Foreign Manufactu ... more
Agilent Technologies Inc. announced that Koh Boon Hwee has been elected chairman of the board, effective at the end of today’s shareholders’ meeting. Koh, who has been a member of Agilent’s board since 2003, replaces James G. Cullen, who served as chairman since 2005 and will continue as a ... more
- 1Groundbreaking experimental method will speed up protein analysis substantially
- 2State-of-the-art text mining technologies for chemistry
- 3Shimadzu acquires specialist for isotope labeled standards
- 4Tiny nanoparticles offer significant potential in detecting and treating disease
- 5Eurofins expands its footprint in the Balkan region
- 6Eurofins acquires clinical diagnostics company in Italy
- 7More durable, versatile wearable for diabetes monitoring
- 8New sensors could enable more affordable detection of pollution and diseases
- 9Waters Corporation elects Flemming Ornskov to Board of Directors
- 10New femto-camera with quadrillion fractions of a second resolution
- More durable, versatile wearable for diabetes monitoring
- Bacterial organizational complexities revealed
- Waters Corporation elects Flemming Ornskov to Board of Directors
- New sensors could enable more affordable detection of pollution and diseases
- Research on crucial cutting enzyme maps sites of DNA damage in leukemias and other cancers